Chemical genoprotection: Reducing biological damage to as low as reasonably achievable levels

Dentomaxillofacial Radiology

Volumn 40, Issue 5, 2011, Pages 310-314

  Alcaraz, M ^a   Armero, D ^a   Martinez Beneyto Y ^a   Castillo, J ^a,b   Benavente Garcia O ^a,b   Fernandez, H ^a   Alcaraz Saura, M ^a   Canteras, M ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b 80320 Alcantarilla   (Spain)

Author keywords

Antimutagenic agents; Antioxidant; Micronuclei; Radiation effects

Indexed keywords

ABIETANE DERIVATIVE; AMIFOSTINE; ANTIMUTAGENIC AGENT; ANTIOXIDANT; APIGENIN; ASCORBIC ACID; CATECHIN; CINNAMIC ACID DERIVATIVE; DELTA TOCOPHEROL; DELTA-TOCOPHEROL; DEPSIDE; DIOSMIN; PLANT EXTRACT; RADIOPROTECTIVE AGENT; ROSMARINIC ACID; RUTOSIDE; SALVIN; TOCOPHEROL;

ANALYSIS OF VARIANCE; ARTICLE; CELL CULTURE; CYTOKINESIS; DIET; DNA DAMAGE; DRUG EFFECT; FEMALE; HUMAN; LYMPHOCYTE; MICRONUCLEUS TEST; RADIATION EXPOSURE; RADIOMETRY; X RAY;

AMIFOSTINE; ANALYSIS OF VARIANCE; ANTIMUTAGENIC AGENTS; ANTIOXIDANTS; APIGENIN; ASCORBIC ACID; CATECHIN; CELLS, CULTURED; CINNAMATES; CYTOKINESIS; DEPSIDES; DIET; DIOSMIN; DITERPENES, ABIETANE; DNA DAMAGE; FEMALE; HUMANS; LYMPHOCYTES; MICRONUCLEUS TESTS; PLANT EXTRACTS; RADIATION-PROTECTIVE AGENTS; RADIOMETRY; RUTIN; TOCOPHEROLS; X-RAYS;

EID: 79959849310     PISSN: 0250832X     EISSN: None     Source Type: Journal    
DOI: 10.1259/dmfr/95408354     Document Type: Article

References (37)

1. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). UNSCEAR 2001 Report. Hereditary Effects of Radiation. United Nations Publications, Vol II, Sales Nos. E00IX. Available from: http://www.unscear.org/ docs/reports/2001/2001Annex-pages%208-160.pdf.
2. Alcaraz M, Martínez-Beneyto Y, Pérez L, Jódar S, Velasco E, Canteras M. The status of Spain's dental practices following the European Union directive concerning radiological installations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;98:476-482. (Pubitemid 39359199)
3. Alcaraz M. Dental radiology in Spain (1st edn). Murcia: Spanish Council of Nuclear Safety-Service of Publications of the University of Murcia, 2008 (in Spanish).
4. Prasad KN. Rationale for using multiple antioxidants in protecting humans against low doses of ionizing radiation. Br J Radiol 2005;78:485-492. (Pubitemid 40852540)
5. Castillo J, Benavente-García O, Lorente J, Alcaraz M, Redondo A, Ortuño A, et al. Antioxidant activity and radioprotective effects against chromosomal damage induced in vivo by X-rays of flavan-3-ols (procyanidins) from grape seeds (Vitis vinifera): Comparative study versus other phenolic and organic compounds. J Agr Food Chem 2000;48:1738-1745. (Pubitemid 30331518)
6. Benavente-García O, Castillo J, Lorente J, Alcaraz M. Radioprotective effects in vivo of phenolics extracted from Olea europaea L. leaves against X-ray-induced chromosomal damage: comparative study versus several flavonoids and sulfur-containing compounds. J Med Food 2002;5:125-135. (Pubitemid 35283417)
7. Fenech M, Morley A. Measurement of micronuclei in lymphocytes. Mutation Res 1985;147:29-36. (Pubitemid 15111220)
8. International Atomic Energy Agency. Cytogenetic analysis for radiation dose assessment. A manual. Techical Reports Series no 405. Vienna, Austria: IAEA, 2001.
9. Fenech M. Cytokinesis-block micronucleus cytome assay. Nat Protoc 2007;2:1084-1104. (Pubitemid 46901289)
10. Sarma L, Kesavan PC. Protective effects of vitamin C and E against γ-ray-induced chromosomal damage in mouse. Int J Radiat Biol 1993;63:759-764. (Pubitemid 23186547)
11. Feinendegen LE. Significance of basic and clinical research in radiation medicine: challenges for the future. Br J Radiol 2005; Supplement 27:185-195.
12. Schmid W. The micronucleus test. Mutation Res 1975;31:9-15.
13. Baliga MS, Jagetia GC, Venkatesh P, Reddy R, Ullor JN. Radioprotective effect of abana, a polyherbal drug following total body irradiation. Br J Radiol 2004;77:1027-1035. (Pubitemid 40057800)
14. Prasad KN, Cole WC, Haase GM. Radiation protection in humans: extending the concept of as low as reasonably achievable (ALARA) from dose to biological damage. Br J Radiol 2004;77:97-99. (Pubitemid 38313220)
15. Sarma L, Devasagayan TPA, Mohan H, Mittal JP, Kesavan PC. Mechanism of protection by buthionine sulphoximine against γ ray-induced micronuclei in polychromaytic erythrocytes of mouse bone marrow. Int J Radiat Biol 1996;69:633-643.
16. Abraham SK, Sarma L, Kesavan PC. Protective effects of chorogenic acid, curcumin and β-carotene against γ-radiationinduced in vivo chromosomal damage. Mutat Res 1993;303:109-112. (Pubitemid 23323335)
17. Castillo J, Benavente-García O, Del Baño MJ, Lorente J, Alcaraz M, Dato MJ. Radioprotective effects against chromosomal damage induced in human lymphocytes by gamma-rays as a function of polymerization grade of grape seed extracts. J Med Food 2001;4:117-123.
18. Del Baño MJ, Castillo J, Benavente-García O, Lorente J, Martín - Gil R, Acevedo C, et al. Radioprotective-antimutagenic effects of rosemary phenolics against chromosomal damage induced in human lymphocytes by gamma-rays. J Agr Food Chem 2006;54:2064-2068.
19. Popova L, Kishkilova D, Hadjidekova VB, Hristova RP, Atanasova P, Hadjidekova VV, et al. Micronucleus test in buccal epithelium cells from patients subjected to panoramic radiography. Dentomaxillofac Radiol 2007;36:168-171. (Pubitemid 46999160)
20. Cerqueira EMM, Meireles JRC, Lopes MA, Junqueira VC, Gomes-Filho IS, Trindade S, et al. Genotoxic effects of X-rays on keratinised mucosa cells during panoramic dental radiography. Dentomaxillofac Radiol 2008;37:398-403.
21. Navarro JL, Alcaraz M, Gómez-Moraga A, Vicente V, Canteras M. Absence of chromosomic and genotoxic damage from the radiation dose administered in scintigraphic examinations. Rev Esp Med Nucl 2004;23:174-182.
22. Alcaraz M, Gómez-Moraga A, Dato MJ, Navarro JL, Canteras M. Efecto genotóxico inducido por la exposición a rayos X durante exploraciones complejas de radiodiagnóstico médico. Oncología 2002;25:159-168 (in Spanish).
23. Serna A, Alcaraz M, Navarro JL, Acevedo C, Vicente V, Canteras M. Biological dosimetry and Bayesian analysis of chromosomal damage in thyroid cancer patients. Radiat Prot Dosimetry 2007;19:1-9.
24. Castillo J, Alcaraz M, Benavente-García O. Antioxidant and radioprotective effects of olive leaf extract. In: Preedy VR, Watson RR (eds). Olives and olive oil in health and disease prevention. Oxford: Academic Press, 2010, pp 951-958.
25. Benavente-García O, Castillo J, Lorente J, Alcaraz M, Yánez J, Martínez C, et al. Antiproliferative activity of several phenolic compounds against melanoma cell lines. Agroo Food Industries Hi-tech 2005;16:30-34.
26. Benavente-Garcia O, Castillo J, Marín F, Ortuño A, del Rio JA. Uses and properties of citrus flavonoids. J Agr Food Chem 1997;45:4505-4515.
27. Martínez-Conesa C, Vicente V, Yáñez MJ, Alcaraz M, Canteras M, Benavente-García O, et al. Treatment of metastatic melanoma B16F10 by the flavonoids tangeretin, rutin, and diosmin. J Agr Food Chem 2005;53:6791-6797.
28. Yáñez J, Vicente V, Alcaraz M, Castillo J, Benavente-García O, Canteras M, et al. Cytotoxicity and antiproliferative activities of several phenolic compounds against three melanocytes cell lines: relationship between structure and activity. Nutr Cancer 2004;49:191-199. (Pubitemid 39487879)
29. Benavente-García O, Castillo J, Alcaraz M, Vicente V, del Rio JA, Ortuño A. Beneficial action of citrus flavonoids on multiple cancer-related biological pathways. Current Cancer Drug Targets 2007;7:3325-3334.
30. Castillo J, Piedad M, Marchante C, del Baño MJ, Lorente J, Benavente García O, et al. Citroflavonoids and Flavon-3-ols. High radioprotective capacity and prospects for health. Nutrafoods 2002;1:27-39.
31. Alcaraz M, Acevedo C, Castillo J, Benavente-García O, Armero D, Vicente V et al. Liposoluble antioxidants provide an effective radioprotective barrier. Br J Radiol 2009;82:605-609.
32. Hall P, Boice JD, Berg G. Leukaemia incidence after iodine-131 exposure. Lancet 1992;340:1-4.
33. Ron E, Doody MM, Becker DV, Brill AB, Curtis RE, Goldman MB, et al. Cancer mortality following treatment for adult hyprthyroidism. JAMA 1998;280:347-355. (Pubitemid 28503219)
34. Koukourakis MT. Amifostine in clinical oncology: current use and future applications. Anticancer Drugs 2002;13:181-209.
35. Kouvaris JR, Koloulias VE, Vlahos LJ. Amifostine: the first selective-target and broad-spectrum radioprotector. Oncologist 2007;12:738-47. (Pubitemid 47036208)
36. Del Baño MJ, Castillo J, Benavente-García O, Lorente J, Martín-Gil R, Acevedo C, et al. Radioprotective-antimutagenic effects of rosemary phenolics against chromosomal damage induced in human lymphocytes by γ-rays. J Agric Food Chem 2006;54:2064-2068.
37. Sánchez Campillo M, Gabaldon JA, Castillo J, Benavente- García O, Del Baño MJ, Alcaraz M, et al. Rosmarinic acid, a photoprotective agent against UV and other ionizing radiations. Food Chem Toxicol 2009;47:386-392.